Levothyroxine Sodium Tablet
Product Images NDC 51655-727

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 727 52 Master Bottle Label Approval Rev A 06 21)

Label (51655 727 52 Master Bottle Label Approval   Rev A 06 21)
This is a description for Levothyroxine Sodium Tablets, used for thyroid hormone replacement in patients with hypothyroidism. The tablets come in a 150 mcg dosage with 30 tablets per package, and is only available with a prescription. The tablets should be stored at a temperature between 20-25°C (68°-77°F), with excursions allowed between 15°-30°C (59°-86°F). The tablets should be kept out of reach of children, and protected from moisture and light. This particular product was repackaged by Northwind Pharmaceuticals from another product previously labeled 47781-662-XX, and the manufacturing information includes details on lot, S/N and expiration date.*
FDA Label Image

Levothyroxine-structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.